ChristineMaryMcMahonMD

Oncology • Aurora, CO

Physician

Join to view full profile

Dr. McMahon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. McMahon's full profile

Already have an account?

Office
1665 Aurora Ct
Aurora, CO 80045
Phone+1 720-848-0000

Education & Training

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2018
University of Pennsylvania Health SystemResidency, Internal Medicine, 2012 - 2015
Duke University School of MedicineClass of 2012

Certifications & Licensure

CO State Medical License 2020 - 2025
WY State Medical License 2021 - 2025
PA State Medical License 2012 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

8 citations
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia.
Jonathan A Gutman, Amanda Winters, Andrew Kent, Maria Amaya, Christine McMahon
Haematologica. 2023-10-01
47 citations
Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AM...
Daniel A. Pollyea, Amanda Winters, Christine McMahon, Marc Schwartz, Craig T. Jordan
Bone Marrow Transplantation. 2021-10-13
56 citations
Relapsed T Cell ALL: Current Approaches and New Directions
Christine M. McMahon, Selina M. Luger
Current Hematologic Malignancy Reports. 2019-04-01

Lectures

Longitudinal Monitoring of AML Tumors with High-Throughput Single-Cell DNA Sequencing Reveals Rare Clones Prognostic for Disease Progression and Therapy Response
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Impact of Leukapheresis and Time to Chemotherapy on Outcomes of Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Presenting with Hyperleukocytosis: An ...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018